In inflammatory diseases such as rheumatoid arthritis, functions of chondrocytes including synthesis of matrix proteins and proteinases are altered through interactions with cells of the infiltrating pannus. One of the major secreted products of mononuclear inflammatory cells is IL-1. In this study we found that recombinant human IL-1f suppressed synthesis of cartilage-specific type II collagen by cultured human costal chondrocytes associated with decreased steady state levels ofal(II) and al(IX) procollagen mRNAs. In contrast, IL-1 increased synthesis of types I and III collagens and levels of al(I), a2(I), and al(III) procollagen mRNAs, as we described previously using human articular chondrocytes and synovial fibroblasts. This stimulatory effect of IL-1 was observed only when IL-1-stimulated PGE2 synthesis was blocked by the cyclooxygenase inhibitor indomethacin. The suppression of type II collagen mRNA levels by IL-1 alone was not due to IL-i-stimulated PGE2, since addition of indomethacin did not reverse, but actually potentiated, this inhibition. Continuous exposure of freshly isolated chondrocytes from day 2 of culture to approximately half-maximal concentrations of IL-1 (2.5 pM) completely suppressed levels of type II collagen mRNA and increased levels of types I and III collagen mRNAs, thereby reversing the ratio of al(II)/al(I) procollagen mRNAs from > 6.0 to < 1.0 by day 7. IL-i, therefore, can modify, at a pretranslational level, the relative amounts of the different types of collagen synthesized in cartilage and thereby could be responsible for the inappropriate repair of cartilage matrix in inflammatory conditions.
Introduction
In disorders such as rheumatoid arthritis interactions of inflammatory cells with the normal resident populations of cells present in cartilage, bone, and synovium results in destruction of joint tissues (1) . It is generally accepted that erosion of cartilage collagen occurs in areas contiguous with the proliferating synovial pannus and to some extent at the cartilage surface exposed to synovial fluid (2, 3) . Loss of cartilage proteoglycan, however, occurs early in the disease and is widespread throughout the cartilage and not limited to the synovialpannus junction (4) . Degradation of collagen has also been observed in midzone pericellular regions of articular cartilage in humans with arthritis and in certain animal models of inflammation (4, 5) . Chondrocytes can be induced to produce substances involved in breakdown of their own matrix by products of cells of the rheumatoid synovium (6) (7) (8) or isolated inflammatory cells (7, 9) . Since chondrocytes normally function to produce new extracellular matrix and to repair the damaged collagen network (10) , inflammatory mediators might also influence the synthesis of structural matrix components involved in these attempts at repair (1 1) .
IL-I is an inflammatory mediator produced predominantly by monocytes that stimulates synthesis of PGE2, neutral metalloproteinases (such as collagenase), and serine proteinases (including plasminogen activator) by human chondrocytes and synovial fibroblasts (12) (13) (14) (15) (16) (17) (18) . We and others have demonstrated that IL-I also increases synthesis of types I and III collagens by dermal fibroblasts (19) (20) (21) (22) . In human chondrocytes and synovial fibroblasts, however, IL-1-induced increases in type I collagen synthesis and mRNA levels can be demonstrated only when ambient levels of PGE2 are suppressed by the cyclooxygenase inhibitor indomethacin (20) . The purpose of the present studies was to determine whether the synthesis of the major cartilage-specific collagen, type II collagen, is modulated by IL-1.
We previously observed that in chondrocytes the T lymphocyte product, IFN-7y, decreases the synthesis of types I, II, and III collagens and the levels of their associated procollagen mRNAs (23). These effects of IFN-y are not modulated by PGE2. In the present study, we found in early primary cultures of human costal chondrocytes that IL-I suppresses type II collagen synthesis as well as the levels of a 1(II) procollagen mRNA. In contrast to the effects of IL-I on the synthesis of types I and III collagens, the addition of indomethacin does not overcome the suppression of type II collagen synthesis but even potentiates it. Furthermore, our results indicate that this suppression of cartilage-specific type II collagen synthesis by IL-I is exerted at a pretranslational level.
lated by dispersion with proteinases as described previously (23), except that serum was not present in the final incubation of costal cartilage with collagenase (Worthington Biochemical Corp., Freehold, NJ). A single cell suspension was obtained after incubation for 36-48 h with > 95% of the cells viable as estimated by trypan blue exclusion. The chondrocytes were plated, unless otherwise indicated, at a density of -2.0 X 104 cells/cm2 in 22-mm diam wells (Tissue Culture Cluster 12; Costar, Cambridge, MA) or in 100-mm diam dishes (Falcon Labware, Oxnard, CA) and cultured in Dulbecco's modified Eagle's medium (DME) with 10% FCS with changes of medium every 3-4 d. The collagens synthesized by human chondrocytes cultured under these conditions were characterized previously (23). Cells isolated from costal cartilage from three different individuals were used for the experiments described in this study. Similar results were obtained using costal chondrocytes isolated from five additional specimens.
Collagen synthesis. 1 or 2 wk primary cultures of chondrocytes in triplicate 22-mm wells were preincubated without or with human recombinant IL-11I (24) (kindly provided by Drs. Paul Wingfield and Alan Shaw, Biogen, Geneva, Switzerland) for 24 or 48 h in DME with 10% FCS (0.75 ml per well). The cells were then labeled with L-[5-3H]proline (22 Ci/mmol; Amersham Corp., Arlington Heights, IL) in the absence of serum for a further 24 h at 370C. Labeled medium proteins and pepsin-resistant collagens were analyzed by SDS-PAGE (5% acrylamide, 12-cm path length) and fluorography and DNA content in cell layers was measured as described previously (20, 23). In some cases the pepsin-resistant collagen bands were excised from gels, incubated for 2 h at 250C with 10 mg/ml of CNBr in 70% formic acid (25) Ag/ 107 cells as measured by absorption at 260 nm and the average ratio of absorption at 260:280 was -2.08. Dot blot and Northern blot hybridizations. Dot blots of cytoplasmic or total RNA were performed as described (20, 23). For Northern blot analysis total cellular RNAs were denatured by treatment with formaldehyde-formamide, electrophoresed on 0.8% agarose gels containing 0.22 M formaldehyde, and transferred to nitrocellulose paper in 20X SSC buffer (I X SSC = 0.15 M NaCl, 0.015 M sodium citrate, pH 7.5). Staining of the 28S and 18S bands with EtBr was used to monitor quality of the RNA preparation and uniform loading of RNA in all of the lanes. Nick translation, prehybridization, and hybridization were performed as described (23). The type I procollagen cDNA probes used were Hf677, a 1,500-bp cDNA encoding part of the al(I) procollagen subunit (29), and Hfl 131, a 1,500-bp cDNA encoding part of the a2(I) procollagen subunit (30) Prostaglandin assay. Chondrocyte-conditioned medium was removed from cells and stored at -20'C until assay. Concentrations of PGE2 in the culture medium were determined using the PGE2 '25I-RIA kit (DuPont, New England Nuclear, Boston, MA). Standard PE2 was obtained from Pharmacia Fine Chemicals (Piscataway, NJ).
Results
In our previous studies of human articular (Fig. 1 A) . The predominant species of procollagen mRNA in these cells was al(II) (5.5 kb). However, al(I) procollagen mRNA (5.9 and 7.2 kb) was also present in lesser abundance. The levels of both a 1(II) and a1(I) procollagen mRNAs were markedly decreased in cells incubated with IL-1 alone. Although the IL-1-induced decrease in a I(I) procollagen mRNA levels was reversed by coincubation with indomethacin, addition of this cyclooxygenase inhibitor did not overcome the suppression of the levels of a I(II) procollagen mRNA, but potentiated this suppression. The suppression by IL-1 of the levels of a 1(I) mRNA could be ascribed to the IL-1-induced increases in endogenous PGE2, since coincubation of cells with IL-1 and indomethacin completely reversed this inhibition and unmasked a stimulatory effect on the major (5.9 kb) polymorphic al(I) procollagen mRNA species. Furthermore, addition of 100 ng/ml of PGE2 to cultures incubated with IL-I in the presence of indomethacin suppressed the levels of a1(I) procollagen mRNA to those found with IL-I alone. In contrast, POE2 overcame the further suppression by indomethacin of IL-1-induced decrease in levels of a 1(11) procollagen mRNA but did not restore these levels to control values. In overexposed autoradiographs ( Fig. 1 B) , IL-I alone suppressed the levels of a2(I) (5.5, 5.7, and 6.2 kb) and a I (III) (4.5 and 6.2 kb) procollagen mRNAs and indomethacin partially reversed the suppression of a2(I) procollagen mRNA while unmasking a stimulatory effect particularly on the 4.5-kb transcript of a 1(III) mRNA. We have previously reported that a2(I) procollagen mRNA levels are not as tightly regulated as levels of a (I) procollagen mRNA (20, 23, 36). Similar effects of IL-1 and indomethacin were observed using articular chondrocytes at day 14 of primary culture, although a 1(I) was more abundant than a 1(II) procollagen mRNA ( Fig. 1 B) in these cultures. These changes in procollagen mRNA levels could not be accounted for by any changes in #l-actin mRNA levels (data not shown).
IL-l also suppressed the levels of mRNA for a I(IX) procollagen, another cartilage-specific collagen. Northern blot analyses of a I (IX) procollagen mRNA from two different costal chondrocyte cultures, including that shown in Fig. 1 , are shown in Fig. 2 . While the signal for type IX procollagen mRNA was relatively strong in control or indomethacintreated cultures (-5% of the signal for a 1(11) procollagen mRNA), IL-I completely suppressed the levels of a l(IX) procollagen mRNA. Further modulation of the IL-1-suppressed signal by indomethacin or PGE2 was not discernible.
Changes in cellular morphology were also noted in cultures of chondrocytes incubated for 48 h with IL-1, indomethacin, and PGE2. Increased mitotic figures were observed in the presence ofindomethacin (Fig. 3, panel 2) . Cells with stellate shape were found in cultures incubated with IL-1 alone, (Fig. 3,  panel 3 ) or with supplements of PGE2 (Fig. 3, panel 5 increase in the numbers of cells with fibroblast morphology was observed in cultures incubated with IL-1, particularly in the presence of indomethacin (Fig. 3, panel 4) , a condition in which the most marked enhancement of synthesis of types I and III collagens and levels of procollagen mRNA was observed.
We had previously determined that -2. (Fig. 4  B) . The synthesis of al(III) collagen, identified by delayed reduction was stimulated at all time points by IL-1 alone and this stimulation was further enhanced in the presence of indomethacin. In overexposed SDS-PAGE gels (data not shown), a I(III) or a2(I) collagen chains were not discerned at day 7 unless the cells had been exposed to IL-1. In addition, increased amounts of a2(I) collagen were observed at days 7, 13, and 16 after continuous incubation with IL-I in the presence of indomethacin but not with IL-I alone. This stimulation of the synthesis of a2(I) collagen chains was no longer apparent by day 20 and the stimulatory effect on the synthesis oftype III collagen had diminished. Labeling in the region of the al collagen band was also increased by IL-I in the presence of indomethacin compared with IL-I alone at days 7, 13, and 16 but not at day 20. The a I collagen band in medium from cells incubated with IL-I migrated more slowly than that from control cells at all time points and coincided with the migration of the a I(!) collagen band from the rat tail tendon collagen standard. The labeled a I collagen bands ofhigher mobility present in medium from control and indomethacin-treated cells and most easily distinguished at day 7 To explore this possibility further, cytoplasmic RNAs were extracted from parallel cultures on days 7, 13, 16, and 20 and levels of a 1(I), a2(I), aI(II), and a 1(III) procollagen mRNAs analyzed by dot blot hybridization (Fig. 5 and Table I ). Through day 20, type II was the predominant procollagen mRNA in control cells or cells incubated with indomethacin. In chondrocytes incubated under control conditions, the relative abundance of types I and III procollagen mRNAs increased with time in culture, whereas the levels of type II procollagen mRNA remained relatively constant. As shown in Fig. 5 and Table I , incubation with IL-l increased the levels of a1(I) and a 1(III) procollagen mRNAs at days 7, 13, and 16. The suppression by IL-I alone of the levels of a 1(I) procollagen mRNA observed in the short-term incubations described above, which we ascribed to IL-l-induced increases in ambient PGE2 concentrations, was not observed during continuous exposure likely due to downregulation of cellular responsiveness to PGE2 as discussed below (see Table III ). On the other hand, incubation with IL-I alone or in the presence ofindomethacin, dramatically suppressed the levels of a 1(II) procollagen mRNA at all time points and reversed the ratio of a 1(11)/a (I) procollagen mRNAs from > 6.0 to < 1.0 (Table I) .
In previous studies (20, 23) and in the experiments described above the chondrocytes were plated at 1. Fig. 5 . Ratios of different procollagen mRNAs were also determined after correcting for specific activities of the 32P-labeled DNA probes. collagen synthesis is at the level of a I(I) rather than a2(I) procollagen mRNA (20, 23, 36). Incubation with IL-1 in the presence of indomethacin therefore, increased the ratio of a l(I)/a2(I) procollagen mRNAs. Levels of a 1(III) procollagen mRNA were not altered at the lowest plating density, but were increased by IL-I in the presence of indomethacin at the higher cell-plating densities. Thus, the costal chondrocytes with respect to the expression of type I collagen appeared to be particularly sensitive to fluctuations in concentrations of PGE2 in the culture medium.
When a sensitive RIA, employing ['25I]PGE2, was used to determine ambient PGE2 concentrations, we found that concentrations of PGE2 in medium from costal chondrocytes incubated under control conditions for 48 h were 10-250 pg/ml (compared with 1-10 ng/ml in culture medium from human articular chondrocytes [20] ). Despite the marked differences in amounts of PGE2 synthesized by these different chondrocytes under basal conditions, the magnitude of stimulation by IL-1 of ambient PGE2 concentrations (-40-to 400-fold) in the costal chondrocytes was comparable to that previously observed in articular chondrocyte cultures (20). The levels of PGE2 in two of the experiments described above are shown in Tables III and IV . High concentrations of PGE2 were maintained during long-term incubation with IL-i (Table III) . Incubation for 24 or 48 h with IL-I in the presence or absence of indomethacin had no significant effect on cell number or DNA content. In long-term incubation, however, cell numbers increased progressively through day 20. Treated/control ratios on day 20 were: indomethacin, 1.45; IL-1, 1.79; IL-l plus indomethacin, 1.87). These increases in cell number did not account for the increases in collagen synthesis or cellular levels of procollagen mRNAs under these conditions.
Discussion
We showed recently that recombinant preparations of murine and human IL-1 stimulated the synthesis of types I and III collagens and fibronectin and levels of associated procollagen mRNAs in cultured human and synovial fibroblasts and articular chondrocytes (20). The latter synthesized little type II collagen at the time we examined them. This stimulatory effect was observed, however, only when IL-1-induced increases in endogenous PGE2 synthesis were blocked by indomethacin (20) . In the present studies, human costal chondrocytes, which continue to synthesize type II collagen throughout primary culture, were used to further examine these effects. Since costal chondrocytes could be obtained in large numbers, they provided a model to examine regulation of synthesis of this carti- Table I . Cytoplasmic RNA was extracted on the days indicated one day after the previous medium change and blotted on nitrocellulose as equivalents of DNA in the nuclear pellets at three serial dilutions (0.5, 0.25, and 0.125 ug DNA equivalents, respectively). In previous studies we noted that IL-I -induced increases in PGE2 levels in culture medium can alter the phenotypic expression of connective tissue cells (19, 20) . In synovial fibroblasts and articular and costal chondrocytes the suppression of type I collagen synthesis is probably secondary to the effects of increased ambient concentrations of PGE2 induced by IL-1. Although basal levels of PGE2 in cultures of costal chondrocytes are 1-5% those of articular chondrocytes, the synthesis ofPGE2 by both cell types is increased by approximately the The augmentation by IL-1 of synthesis of types I and III collagens when the cytokine-induced increase in endogenous PGE2 production is inhibited is reminiscent of the "upregulation" of hormone-induced adenylate cyclase responses observed in synovial cells and chondrocytes coincubated with IL-1 and indomethacin (42) (43) (44) . Since responses to forskolin are also augmented by preincubation with IL-1 (45), IL-I may modulate indirectly the adenylate cyclase/G protein complex. Such "crosstalk" between adenylate cyclase-coupled signal pathways and the inositol lipid pathway, with its distinct G protein has been demonstrated (46, 47). Although the cell surface receptors for IL-I have been measured and characterized in several responsive cell types (48) , the signal pathways involved in transducing IL-I effects have not yet been defined.
One of the interesting observations that has resulted from the present study is that IL-1 produces differential effects on the expression of genes for types I and III collagens compared with types II and IX collagens. Since the effects on protein synthesis parallel those on the respective mRNA levels, control is most likely pretranslational, probably occurring at a transcriptional level, although effects on mRNA stability have not yet been ruled out. Although it is not known how IL-I acts intracellularly, several of its effects are similar to those of phorbol esters including stimulation of the expression of the procollagenase gene (17). It is tempting to speculate that the procollagen genes would contain cis-acting DNA sequences similar to those responsive to phorbol esters, which would function in a different manner in regulating transcription of the types I and III compared to types II and IX procollagen genes. Although one phorbol ester-inducible sequence is recognized by activator protein 1 (AP-1) (49, 50), the trans-acting factors responsible for the regulatory effects of IL-I on procollagen gene expression have not been defined. The DNA sequences required for regulation by cAMP and phorbol ester map to the same region of the proenkephalin gene promoter (51) suggesting that the two intracellular signaling pathways converge to regulate a common trans-acting factor. The activator protein-2 (AP-2) also responds to both cAMP and phorbol ester (52). Since IL-l and PGE2 have different effects on expression of different collagen genes, it is possible that signals induced by these mediators may interact with the different collagen genes (on different chromosomes) in specific ways.
A number of the previously described effects of soluble mononuclear cell products on mesenchymal cells can be attributed to IL-1 based on studies using recombinant preparations ofthis cytokine. It is likely that other factors produced by mononuclear cells have similar and even synergistic effects. For example, in preliminary work in our laboratory tumor necrosis factor-a and tumor necrosis factor-# (lymphotoxin) alter synthesis of types I and III collagens in synovial fibroblasts in a manner similar to IL-I (Amento, E. P., M. Hayes, and S. M. Krane, unpublished observations). Furthermore these cytokines act synergistically with transforming growth factor-#. In vivo, therefore, it is likely that the regulation of collagen synthesis results from the cumulative effects of different ligands several of which are products of mononuclear cells present at sites of inflammation.
Mediators such as IL-I could also have a role in cartilage development, analogous to that proposed for ameboid microglia in the developing brain. The ameboid microglia, which are the mononuclear phagocytic cells of the brain, may regulate through signaled release of IL-I the proliferation of astroglia (53, 54) . Cartilage is an avascular tissue, and it is possible that mononuclear phagocytes derived from the circulation alter the chondrocyte phenotype when vascularization takes place in the process of ossification of cartilage in the endochondral sequence. Factors such as IL-I could then alter the chondrocyte phenotype by suppressing synthesis of the cartilage-specific types II and IX collagens and inducing synthesis of type I collagen characteristic of mineralized bone. These
